Actively Recruiting

Age: 18Years - 46Years
FEMALE
NCT06967740

Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs

Led by Nikola Janovska · Updated on 2025-07-31

200

Participants Needed

1

Research Sites

265 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary aim of this study is to develop a recommended clinical practice guideline for managing women with HPV HR (high-risk human papillomavirus) positivity and cervical lesions. Additionally, in collaboration with the Bioptic Laboratory, the study will analyze the integration of HPV HR testing into screening programs for women aged 35, 45, and 55, with a focus on optimizing management strategies for HPV HR-positive women. Research Objectives: * Evaluate spontaneous regression/progression over two years based on HPV HR genotyping (three groups - according to Alinity: high, intermediate, and low risk). * Assess spontaneous regression/progression over two years based on HPV HR genotyping and viral load in HPV-vaccinated vs. non-vaccinated patients. * Evaluate spontaneous regression/progression over two years based on methylation results. * Assess spontaneous regression/progression over two years based on CinTec plus results.

CONDITIONS

Official Title

Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs

Who Can Participate

Age: 18Years - 46Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Provided informed consent
  • Have a cervical biopsy confirming a high-grade lesion
  • Aged between 18 and 46 years
  • Colposcopically visible transformation zone
  • Unvaccinated for HPV
  • Cytology results excluding AIS, adenocarcinoma, squamous cell carcinoma, and AGC NEO
Not Eligible

You will not qualify if you...

  • Cytology showing AIS, AGC NEO, adenocarcinoma, or squamous cell carcinoma
  • Immunosuppression
  • Active autoimmune disease
  • History of cervical cryodestruction
  • HPV vaccination prior to study start

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Kralovske Vinohrady

Prague, Czechia, 10034

Actively Recruiting

Loading map...

Research Team

L

Lukas Rob, Prof. MUDr., Csc.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here